期刊文献+

链脲佐菌素诱导的糖尿病大鼠尿podocalyxin排泄的动态变化 被引量:4

Dynamic changes of urinary podocalyxin excretion and its significance in STZ-induced diabetic rats
下载PDF
导出
摘要 目的观察链脲佐菌素(STZ)诱导的糖尿病大鼠足细胞标志蛋白podocalyxin随尿排泄的动态变化并探讨其意义。方法 STZ 65 mg/kg腹腔注射后建立糖尿病大鼠模型,正常大鼠注射等量枸橼酸缓冲液作为对照组(NC组)。分别于0周、2周、4周和8周监测两组大鼠血糖、尿白蛋白(UALB)及尿沉渣中PCX含量(UPCX)和8周末HbA1c,为消除尿量影响分别用尿肌酐(UCr)校正称为UACR(UALB/UCr)及UPCR(UPCX/UCr)。结果 (1)与健康对照组比较,糖尿病大鼠各时间点血糖和8周时HbA1c显著增高,P<0.01;(2)与健康对照组比较,2周时糖尿病大鼠UACR及UPCR即显著增高,并随时间不断增长;(3)糖尿病大鼠UPCR与UACR呈正相关(r=0.86,P<0.01)。结论足细胞损伤参与糖尿病肾脏病变的发生,尿PCX检测可作为反映糖尿病早期肾损害的指标之一。 Objective To investigate the dynamic changes of urinary podocalyxin excretion and its clinical significance in streptozotocin-induced diabetic rats.Methods Diabetic models were established by a single injection of streptozotocin(STZ 65 mg/kg),then the diabetic rats were assigned into diabetic group after the diabetic model stabilized for one week,healthy rats injected with equal dosage of critic acid buffer solution were served as normal control group(NC group).The peripheral blood glucose,urinary sediment podocalyxin,urinary albumin were determined at the basal,the second week,the fourth week and eighth week in two groups during the observation.To eliminate the impact of urine volume,urinary podocalyxin and urinary albumin concentrations were expressed as urinary UPCX/UCr(UPCR)and UALB/UCr(UACR),respectively.Results(1)Compared with NC group,the levels of blood glucose throughout the study period along with HbA1c at the 8th week in diabetic rats were significantly higher than those in group NC at the same period(P0.01).(2)The level of UACR and UPCR in diabetic model group began to increase significantly at the third weeks after the STZ injection,then increased progressively with the time until the end of the experiment.(3)UPCR was positively related with UACR(r=0.86,P0.01).Conclusion Podocyte injury involves in the development of diabetic nephropathy.Increased urinary podocalyxin excretion appears to be an early biomarker of diabetic kidney injury.
出处 《中国临床保健杂志》 CAS 2011年第2期169-172,I0002,共5页 Chinese Journal of Clinical Healthcare
基金 安徽省自然科学基金(070413255X) 安徽省人才开发基金资助项目(2008Z048)
关键词 糖尿病肾病 白蛋白尿 链脲菌素 大鼠 Sprague-Dawley Diabetic nephropathies Albuminuria Streptozocin Rats Sprague-Dawley
  • 相关文献

参考文献16

  • 1Teiken JM,Audettey J L,Laturnus DI,et al.Podoeyte loss in aging OVE26 diabetic mice[J].Anat Rec(Hoboken),2008,291(1):114-121.
  • 2Choudhury D,Tuncel M,Levi M.Diabetic nephropathy-a multifaceted target of new therapies[J].Discov Med,2010,10(54):406-415.
  • 3Hara M,Yanagihara T,Kihara 1,et al.Apical cell membranes are shed into urine from injured podocytes:a novel phenomenon of podocyte injury[J].J Am Soc Nephrol,2005,16(2):408416.
  • 4Kanno K,Kawachi H,Uchida Y,et al.Urinary sediment podocalyxin in children with glomerular diseases[J].Nephron Clin Pract,2003,95(3):c91-99.
  • 5赵俐丽,叶山东,陈燕,范爱红.2型糖尿病患者尿nephrin排泄量的变化及其临床意义[J].中国临床保健杂志,2009,12(3):253-255. 被引量:7
  • 6Economou CG,Kitsiou PV,Tzinia AK,et al.Enhanced podocalyxin expression alters the structure of podocyte basal surface[J].J Cell Sci,2004,117(Pt 15):3281-3294.
  • 7Nakamura T,Ushiyama C,Suzuki S,et al.Urinary excretion of podocytes in patients with diabetic nephropathy[J].Nephrol Dial Transplant,2000,15(9):1379-1383.
  • 8Riister C,Bondeva T,Franke S,et al.Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes[J].Nephrol Dial Transplant,2008,23(7):2179-191.
  • 9姚全良,詹伦琴.尿液足细胞标记蛋白在2型糖尿病肾病早期诊断中的价值[J].山东医药,2009,49(39):29-30. 被引量:7
  • 10Huby AC,Rastaldi MP,Caron K,et al.Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin[J].PLoS One,2009,4(8):e6721.

二级参考文献8

  • 1Spadlo A,Wyka K, Kowalewska-Pietrzak M, et al. Evaluation of the podoeytes in urine in the nephrofic syndrome in childhood [ J ]. Pol Merkur Lekarski ,2007,22(130) :254-257.
  • 2Camiei M. Urinary detection of podocyte injury [ J ]. Biomed Pharmatother,2007,61 ( 5 ) :245-249.
  • 3Qi J,xiao YF,Zlaang DJ,et al. High glucose downregulates the expression of podoealyxin protein in glomerular podocytes of mice[ J]. Beijing Da Xue Xue Bao,2007,39(2) :167-170.
  • 4Kawachi H,Miyauchi N, Hart GD. Structure and function of podocyte [ J ]. Nippon Rinsho,2006,64 ( Suppl 2) :70-73.
  • 5Habara P, Mareckova H, Sopkova Z, et al. A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine [J]. Folia Biol (Praha) ,2008,54(5) :162-167.
  • 6郭丽琴,陈孝文,刘华锋.足细胞标志蛋白及足细胞疾病[J].中国中西医结合肾病杂志,2008,9(2):173-176. 被引量:9
  • 7柳迎昭,吴晨光,宋丽敏,沈莉敏,姚翡.糖尿病大鼠尿nephrin的检测及意义[J].江苏大学学报(医学版),2008,18(2):115-117. 被引量:8
  • 8孙绍军,杨杰.尿沉渣中Podocalyxin的检测在肾小球疾病中的应用研究[J].现代检验医学杂志,2008,23(5):98-100. 被引量:6

共引文献12

同被引文献37

  • 1杜娟,张素华.糖尿病大鼠肾脏髓质水通道蛋白2的表达和意义[J].中华内分泌代谢杂志,2006,22(1):67-71. 被引量:22
  • 2Shanshan Pang,Yingying Le.Role of Resistin in Inflammation and Inflammation-Related Diseases[J].Cellular & Molecular Immunology,2006,3(1):29-34. 被引量:25
  • 3Bautista-Garcia P, Reyes JL, Martin D, et al. Zonaoccludens-2 protects against podocyte dysfunction induced by ADR in mice[J]. Am J Physiol Renal Physiol, 2013, 304(1): F77-87.
  • 4Rigothier C, Auguste P, Welsh GI, et al. IQGAP1 interacts with components of the slit diaphragm complex in podocytes and is involved in podoeyte migration and permeability in vitro[J]. PLoS One, 2012, 7(5): e37695.
  • 5Kerjaschki D, Sharkey DJ, Farquhar M. Identification and characterization of podocalyxin-the major sialoprotein of the renal glomemlar epithelial cell[J]. J Cell Biol, 1984, 98(4): 1591-1596.
  • 6Alonso-Martin S, Nowakowski A, Larrucea S, et al. Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets[J]. Thromb Res, 2010, 125(6): e300-305.
  • 7Vitureira N, Andres R, Perez-Martinez E, et al. Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation[J]. PLoS One, 2010, 5(8): e12003.
  • 8Schopperle WM, Lee JM, Dewolf WC. The human cancer and stem cell marker podocalyxin interacts with the glucose-3-transporter in malignant pluripotent stem cells[J]. Biochem Biophys Res Commun, 2010, 398(3): 372-376.
  • 9Hsu YH, Lin WL, Hou YT, et al. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Racl guanine nucleotide exchange factor ARHGEF7[J]. Am J Pathol, 2010, 176(6): 3050-3061.
  • 10Larrucea S, Butta N, Arias-Salgado EG, et al. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells[J]. Exp Cell Res, 2008, 314(10): 2004-2015.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部